Savant Capital LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 1.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,218 shares of the pharmacy operator’s stock after acquiring an additional 128 shares during the quarter. Savant Capital LLC’s holdings in CVS Health Corporation were worth $581,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Boston Partners boosted its holdings in shares of CVS Health Corporation by 69.1% during the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after acquiring an additional 2,638,888 shares during the last quarter. LSV Asset Management boosted its holdings in shares of CVS Health Corporation by 44.2% during the 1st quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after acquiring an additional 1,404,384 shares during the last quarter. Canada Pension Plan Investment Board boosted its holdings in shares of CVS Health Corporation by 89.8% during the 2nd quarter. Canada Pension Plan Investment Board now owns 1,851,099 shares of the pharmacy operator’s stock valued at $148,939,000 after acquiring an additional 876,027 shares during the last quarter. NN Investment Partners Holdings N.V. boosted its holdings in shares of CVS Health Corporation by 141.2% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 1,427,210 shares of the pharmacy operator’s stock valued at $114,832,000 after acquiring an additional 835,476 shares during the last quarter. Finally, Swiss National Bank boosted its holdings in shares of CVS Health Corporation by 26.9% during the 1st quarter. Swiss National Bank now owns 3,826,410 shares of the pharmacy operator’s stock valued at $300,373,000 after acquiring an additional 811,100 shares during the last quarter. 81.46% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CVS Health Corporation (NYSE:CVS) opened at 76.49 on Friday. The company has a market cap of $77.76 billion, a PE ratio of 15.24 and a beta of 0.92. The stock’s 50 day moving average is $78.86 and its 200 day moving average is $78.71. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $88.84.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. During the same quarter last year, the firm posted $1.32 EPS. The business’s revenue was up 4.5% on a year-over-year basis. Equities analysts forecast that CVS Health Corporation will post $5.88 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.61%. CVS Health Corporation’s dividend payout ratio (DPR) is 39.92%.

A number of analysts have recently issued reports on CVS shares. Guggenheim reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $95.00 price target on shares of CVS Health Corporation in a report on Monday, October 9th. SunTrust Banks, Inc. set a $85.00 price target on shares of CVS Health Corporation and gave the company a “buy” rating in a report on Thursday, October 12th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $89.68.

In related news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.61, for a total value of $7,186,155.87. Following the completion of the transaction, the executive vice president now directly owns 70,102 shares of the company’s stock, valued at approximately $5,580,820.22. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the completion of the transaction, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The disclosure for this sale can be found here. Insiders have sold a total of 716,625 shares of company stock worth $58,318,431 in the last quarter. Insiders own 0.61% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “CVS Health Corporation (CVS) Stake Increased by Savant Capital LLC” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.watchlistnews.com/cvs-health-corporation-cvs-stake-increased-by-savant-capital-llc/1644866.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.